“I never imagined that my fun childhood frolics in lakes and pools would lead to skin cancers and a scary surgery
on the the top of my head.”
By Julie Bain
My favorite childhood memories are of summer days at a crystal-clear lake in northern Minnesota. My best friend Barbie and I would play in and out of the water all day long. While her skin took on a golden glow, mine would turn hot pink and freckly.
We knew little about the dangers of the sun then. My mom warned me about getting burned. But it wasn’t cool to wear a T-shirt over your cute swimsuit — or a hat. And the tanning lotions we had then were designed to enhance your “deep, dark tan,” not keep you from getting one. Whatever protection they offered washed right off in the water. At night, we slathered Noxzema on our burns while we listened to the Beatles. When our skin started to peel, we thought that was cool.
By my teen years, my summers were less about having fun in the water and more about the futile pursuit of a beach babe tan. I wanted to look like Farrah Fawcett — or my tall, blonde and tan older sister. My friends and I would “lay out” for hours, and while they would achieve that prom-ready patina, I once ended up in the doctor’s office with second-degree, blistered burns.
I finally started to understand the consequences of inheriting my father’s Scottish-Swedish DNA. I learned my lesson and started to protect myself from the sun. But a lot of damage had been done.
Skin Cancer at 25
When I was in my mid 20s and living in Dallas, I noticed a scabby spot on my left thigh that never quite seemed to heal. My doctor said it was probably nothing because I was too young to have skin cancer. My instincts told me it wasn’t nothing. He took a small sample of the tissue for a biopsy. Sure enough, it was a basal cell carcinoma (also known as BCC), the most common type of skin cancer. The doctor took care of it with a simple excision and a Band-Aid. I thought that would be the end of it. I was wrong.
“My forehead was the next target, and soon it became ground zero
for a couple of aggressive BCCs that recurred after treatment.”
My forehead was the next target, and soon it became ground zero for a couple of aggressive BCCs that recurred after treatment. That’s when I learned about Mohs surgery. It’s a technique done in steps so the doctor can look at each section of tissue removed under a microscope while you wait and make sure there are no remaining cancer cells.
When I moved to New York and became a health writer and editor for magazines, I educated myself about skin cancer and became a bit of an expert on BCC. I learned that while some can be aggressive and recur, they almost never metastasize or spread to other areas of the body. But they can be “disfiguring,” as the dermatologists say. That means you could end up with a chunk of your face missing and a big ol’ scar. I learned that I was also at risk for more, and other kinds, of skin cancer.
This Spot Seemed Different
By 2012 I had had six BCCs. I often checked my own skin and knew the signs to look for. Then I noticed a spot that seemed different from the others. It was on my scalp, just above the hairline. It seemed kind of itchy or irritated. I didn’t think much of it at first, since I have sensitive skin, and hair products often make my scalp itch. Or I thought it could be a burn from my straightening iron. A few times I felt a little scab come off. I pointed out the spot to my dermatologist, and she thought it was nothing to worry about.
My little spot didn’t look anything like the ugly lesions I’d seen on websites, but it didn’t go away and I was worried. I trusted my instincts and asked David Kriegel, MD, who had done Mohs surgery on a BCC on my arm, to look at it. Dr. Kriegel, director of the Division of Dermatologic and Mohs Surgery at Mount Sinai Medical Center in New York City, listens very closely when patients say they have a gut feeling. “I always tell patients that skin cancers don’t read textbooks,” he says. “People know their own skin.”
A New (Scary) Diagnosis
A biopsy confirmed it. This was a squamous cell carcinoma, or SCC. It’s the second most common form of skin cancer, with more than a million cases each year in the U.S. Dr. Kriegel recommended Mohs surgery. I knew the cure rate for small SCCs like mine is close to 100 percent with Mohs. But still, the diagnosis scared me, since I also knew that, although it’s pretty rare, some large SCCs can spread, or metastasize, and become life-threatening.
After my diagnosis, the weirdest coincidence happened. I took a cab home, and the driver shared that his mother had died from squamous cell carcinoma. He was devastated. I felt like I’d been punched in the gut. Really, I thought, people die from this? Yes, depending on what study you read, up to 8,800 people in the U.S. die from invasive SCC every year.
The driver told me that he was being treated with a topical medication for actinic keratoses (AKs) — precancers that can develop into SCCs. He got checked out because he promised his mother he would. I promised him I would stay vigilant, too, and use my skills as a journalist to help raise awareness.
My surgery wasn’t fun, but it went fine. Since then, I’ve been diagnosed with a few AKs myself, plus four more BCCs. I still love the lakes of northern Minnesota and visit as often as I can. But now I wear protective swim shirts and hats with pride. I monitor my skin regularly and see my dermatologist every six months for a skin check. And in December 2015 I joined The Skin Cancer Foundation as heath and science editor — a nice way to fulfill my promise to that cab driver and honor his mother.
Julie Bain is health and science editor at The Skin Cancer Foundation. Published on May 20, 2016
Julie Bain is health and science editor at The Skin Cancer Foundation.
Published on May 20, 2016